Quest Diagnostics News

Analysts Have Conflicting Sentiments on These Healthcare Companies: Apellis Pharmaceuticals (APLS), Quest Diagnostics (DGX) and Healthcare Services (HCSG)

TipRanksApr 26 03:08 ET

Quest Diagnostics: A Hold Rating Amid Solid Earnings and Strategic Caution

TipRanksApr 26 02:15 ET

Decoding Quest Diagnostics Inc (DGX): A Strategic SWOT Insight

Yahoo FinanceApr 26 01:05 ET

Quest Diagnostics Is Maintained at Equal-Weight by Barclays

Quest Diagnostics Is Maintained at Equal-Weight by Barclays

Dow JonesApr 25 14:47 ET

Barclays Maintains Equal-Weight on Quest Diagnostics, Raises Price Target to $144

Barclays analyst Stephanie Davis maintains Quest Diagnostics (NYSE:DGX) with a Equal-Weight and raises the price target from $138 to $144.

BenzingaApr 25 14:36 ET

Quest Diagnostics Foundation and Green Bronx Machine Expand Collaboration to Bring Acclaimed Indoor Gardening Curriculum to More Communities and Raise Awareness for Impact of Nutrition Education on Health Equity

The Quest Diagnostics Foundation today announced an expanded collaboration with Green Bronx Machine (GBM), a transformational educational nonprofit...

PR NewswireApr 25 08:22 ET

Express News | Quest Diagnostics Inc : Barclays Raises Target Price to $144 From $138

ReutersApr 25 06:48 ET

Peering Into Quest Diagnostics's Recent Short Interest

Quest Diagnostics's (NYSE:DGX) short percent of float has fallen 16.83% since its last report. The company recently reported that it has 2.55 million shares sold short, which is 2.62% of all regular s

BenzingaApr 24 15:45 ET

Quest Diagnostics Is Maintained at Neutral by Citigroup

Quest Diagnostics Is Maintained at Neutral by Citigroup

Dow JonesApr 24 14:20 ET

UBS Adjusts Price Target on Quest Diagnostics to $146 From $139, Maintains Neutral Rating

UBS Adjusts Price Target on Quest Diagnostics to $146 From $139, Maintains Neutral Rating.

MT NewswiresApr 24 09:48 ET

Express News | Quest Diagnostics : Deutsche Bank Raises Target Price to $136 From $125

Moomoo 24/7Apr 24 08:52 ET

Quest Diagnostics Is Maintained at Buy by Mizuho

Quest Diagnostics Is Maintained at Buy by Mizuho

Dow JonesApr 24 08:04 ET

Mizuho Maintains Buy on Quest Diagnostics, Raises Price Target to $155

Mizuho analyst Ann Hynes maintains Quest Diagnostics with a Buy and raises the price target from $150 to $155.

Analyst UpgradesApr 24 07:53 ET

Quest Diagnostics Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/24/2024 13.39% Mizuho $150 → $155 Maintains Buy 03/20/2024 6.07% Truist Securities → $145 Reiterates Ho

BenzingaApr 24 07:52 ET

Is Now The Time To Look At Buying Quest Diagnostics Incorporated (NYSE:DGX)?

Yahoo FinanceApr 24 07:41 ET

Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), Tactile Systems Technology (TCMD) and Danaher (DHR)

TipRanksApr 24 07:20 ET

Express News | Quest Diagnostics Inc : Barclays Raises Target Price to $150 From $145

Moomoo 24/7Apr 24 06:58 ET

Quest Diagnostics Inc (DGX) Q1 2024 Earnings Call Transcript Highlights: Key Financial Outcomes ...

Yahoo FinanceApr 24 03:02 ET

Express News | Quest Diagnostics Inc : Evercore ISI Raises Target Price to $145 From $140

Moomoo 24/7Apr 24 00:50 ET

Health Care Climbs on Earnings Hopes -- Health Care Roundup

Health-care companies rose amid strong earnings. Quest Diagnostics boosted its projections for 2024 adjusted earnings and revenue after better-than-anticipated first-quarter revenue growth. Shares o

Dow JonesApr 23 17:18 ET